ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $9,606,000 | +323.7% | 155,584 | +166.4% | 6.84% | +276.3% |
| Q3 2014 | $2,267,000 | +45.4% | 58,395 | +29.0% | 1.82% | +53.5% |
| Q2 2014 | $1,559,000 | -63.4% | 45,266 | -54.1% | 1.18% | -69.4% |
| Q1 2014 | $4,259,000 | -68.5% | 98,567 | -71.0% | 3.87% | -55.7% |
| Q4 2013 | $13,538,000 | – | 339,799 | – | 8.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |